.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent oncological research highlights the pivotal role of CHD4 in tumor progression and its complex function within the nucleosome-remodeling and deacetylase (NuRD) complex. As a core ATP-dependent factor, CHD4 governs essential cellular processes like gene expression and DNA damage response. Interestingly, its function depends heavily on the specific tumor environment. While it often drives cancer development, it can also act as a tumor suppressor in certain transcriptional settings. Consequently, understanding these dual roles is vital for developing effective oncology treatments.
Furthermore, CHD4 significantly influences tumor growth by regulating key signaling pathways and maintaining the silencing of tumor suppressor genes. This protein also promotes metabolic adaptation, which helps cancer cells survive under metabolic stress. Beyond its role in growth, CHD4 is a critical player in the DNA damage response (DDR). It facilitates chromatin remodeling at damage sites and assists in cell cycle recovery. Moreover, it guides the selection of specific repair pathways, ensuring genomic stability even during therapeutic stress.
However, the most challenging aspect involves its contribution to treatment resistance. CHD4 helps tumor cells evade the effects of chemotherapy and radiation through several distinct mechanisms. For instance, it regulates drug efflux and stabilizes replication forks during DNA synthesis. Additionally, it alters the tumor immune microenvironment to protect malignant cells from immune detection. Because various non-coding RNAs modulate its stability and localization, CHD4 serves as a central hub for therapeutic evasion. Therefore, targeting this protein could potentially reverse resistance and improve clinical outcomes for cancer patients.
CHD4 is a chromatin-remodeling factor that regulates gene expression and DNA repair. It can either promote tumor growth or suppress it, depending on the specific cellular and transcriptional context.
It promotes resistance by enhancing DNA repair efficiency, increasing drug efflux, and stabilizing replication forks, which allows cancer cells to survive intensive therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of CHD4's dual role in cancer, highlighting its impact on chromatin remodeling, DNA repair, and its contribution to treatment resistance....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
